Chronic Kidney Disease Stage 5 study: VIEWER virtual care platform
Official title CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
ClinicalTrials.gov ID: NCT05726526
What this study is testing
- What it's testing
- The study wants to see if adding the VIEWER virtual care platform to usual care reduces emergency department visits or hospitalizations, or makes patients and providers feel safer with virtual care.
- Who it's for
- Adults with chronic kidney disease stage 5 or end‑stage renal disease.
- What's involved
- Participants will use the VIEWER virtual care platform in addition to their normal care. The platform provides remote monitoring and communication with health professionals.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \>18 years of age
- Patient or primary caregiver can read and speak English
- Patient or patients substitute decision maker is able to provide informed consent
- Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e.
- Have stage 5 CKD (2 measurements of eGFR \ 40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
You likely can't join if
- Inability of self or caregiver assisted self-monitoring using VIEWER
See the full eligibility criteria
- \>18 years of age
- Patient or primary caregiver can read and speak English
- Patient or patients substitute decision maker is able to provide informed consent
- Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
- Have stage 5 CKD (2 measurements of eGFR \ 40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
- Followed in a multidisciplinary CKD clinic
- Inability of self or caregiver assisted self-monitoring using VIEWER
The study team makes the final eligibility decision.
Where it is enrolling
- Winnipeg, Manitoba, Canada
- London, Ontario, Canada
- Scarborough Village, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Winnipeg, Manitoba, Canada; London, Ontario, Canada; Scarborough Village, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.